.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,597,815

« Back to Dashboard
Patent 5,597,815 protects ZEMPLAR and is included in two NDAs. There have been three Paragraph IV challenges on Zemplar. There is one tentative approval for the compound protected by this patent. Additional details are available via the generic ingredient links below.

Protection for ZEMPLAR has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 5,597,815

Title: Prevention of hyperphosphatemia in kidney disorder patients
Abstract:The 19-nor-vitamin D analogs, and particularly 19-nor-1.alpha.,25-dihydroxyvitamin D.sub.2, possess low calcemic and phosphatemic activity while also having the ability to suppress parathyroid hormone (PTH) production. The suppressive effect on PTH secretion of these 19-nor analogs without significant changes in serum calcium or serum phosphorus make them ideal tools for the treatment of secondary hyperparathyroidism in patients having kidney disorders.
Inventor(s): Deluca; Hector F. (Deerfield, WI), Slatopolsky; Eduardo (St. Louis, MO)
Assignee: Wisconsin Alumni Research Foundation (Madison, WI)
Application Number:08/502,288
Patent Claim Types:
see list of patent claims
Use; Composition; Delivery;

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Abbvie
ZEMPLAR
paricalcitol
CAPSULE;ORAL021606-001May 26, 2005RXNo5,597,815*PED► subscribeY
Abbvie
ZEMPLAR
paricalcitol
CAPSULE;ORAL021606-002May 26, 2005RXNo5,597,815*PED► subscribeY
Abbvie
ZEMPLAR
paricalcitol
CAPSULE;ORAL021606-003May 26, 2005DISCNNo5,597,815*PED► subscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc